Nicole Labrosse

Companies

• Halozyme TherapeuticsChief financial officer Feb 11, 2022 to Jun 9, 2026¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• HTHalozyme Therapeutics HALO38,494 shares²$4.7M at $122.96Feb 23, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 23, 2026Shares withheld for tax 3,608 shares at $70.64 of Halozyme Therapeutics²
• Feb 23, 2026Exercised options 6,688 shares of Halozyme Therapeutics²
• Feb 20, 2026Shares withheld for tax 2,876 shares at $70.98 of Halozyme Therapeutics²
• Feb 20, 2026Exercised options 5,332 shares of Halozyme Therapeutics²
• Feb 16, 2026Shares withheld for tax 7,273 shares at $79.44 of Halozyme Therapeutics³
• Feb 16, 2026Exercised options 13,351 shares of Halozyme Therapeutics³
• Feb 16, 2026Shares withheld for tax 2,874 shares at $79.44 of Halozyme Therapeutics³
• Feb 16, 2026Exercised options 5,329 shares of Halozyme Therapeutics³
• Feb 16, 2026Shares withheld for tax 2,747 shares at $79.44 of Halozyme Therapeutics³
• Feb 16, 2026Exercised options 5,093 shares of Halozyme Therapeutics³
• Sep 22, 2025Sold 314 shares at $78.67 of Halozyme Therapeutics⁴
• Sep 22, 2025Sold 1,913 shares at $77.83 of Halozyme Therapeutics⁴
• Sep 10, 2025Sold 13,240 shares at $75.93 of Halozyme Therapeutics⁵
• Sep 10, 2025Sold 6,760 shares at $75.29 of Halozyme Therapeutics⁵
• Sep 10, 2025Exercised options 1,135 shares at $12.49 of Halozyme Therapeutics⁵
• Sep 10, 2025Exercised options 11,271 shares at $12.07 of Halozyme Therapeutics⁵
• Feb 23, 2025Shares withheld for tax 3,601 shares at $57.75 of Halozyme Therapeutics⁶
• Feb 23, 2025Exercised options 6,688 shares of Halozyme Therapeutics⁶
• Feb 16, 2025Shares withheld for tax 2,869 shares at $58.29 of Halozyme Therapeutics⁷
• Feb 16, 2025Exercised options 5,329 shares of Halozyme Therapeutics⁷
• Feb 16, 2025Shares withheld for tax 2,742 shares at $58.29 of Halozyme Therapeutics⁷
• Feb 16, 2025Exercised options 5,093 shares of Halozyme Therapeutics⁷
• Feb 16, 2025Shares withheld for tax 9,400 shares at $58.29 of Halozyme Therapeutics⁷
• Feb 16, 2025Exercised options 17,409 shares of Halozyme Therapeutics⁷
• Feb 15, 2025Shares withheld for tax 741 shares at $58.29 of Halozyme Therapeutics⁷